Please ensure Javascript is enabled for purposes of website accessibility

Forest Laboratories Beats on Both Top and Bottom Lines

By Seth Jayson - Updated Apr 10, 2017 at 12:43PM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Just the facts, Fool.

Forest Laboratories (NYSE: FRX) reported earnings on April 23. Here are the numbers you need to know.

The 10-second takeaway
For the quarter ended March 31 (Q4), Forest Laboratories beat slightly on revenues and beat expectations on earnings per share.

Compared to the prior-year quarter, revenue dropped significantly. Non-GAAP earnings per share contracted significantly. GAAP earnings per share dropped significantly.

Margins contracted across the board.

Revenue details
Forest Laboratories logged revenue of $821.7 million. The 19 analysts polled by S&P Capital IQ hoped for revenue of $806.2 million on the same basis. GAAP reported sales were 22% lower than the prior-year quarter's $1.05 billion.

Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.

EPS details
EPS came in at $0.25. The 19 earnings estimates compiled by S&P Capital IQ forecast $0.16 per share. Non-GAAP EPS of $0.25 for Q4 were 68% lower than the prior-year quarter's $0.78 per share. GAAP EPS of $0.17 for Q4 were 76% lower than the prior-year quarter's $0.72 per share.

Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.

Margin details
For the quarter, gross margin was 78.4%, 90 basis points worse than the prior-year quarter. Operating margin was 3.8%, much worse than the prior-year quarter. Net margin was 5.5%, much worse than the prior-year quarter. (Margins calculated in GAAP terms.)

Looking ahead
Next quarter's average estimate for revenue is $803.9 million. On the bottom line, the average EPS estimate is $0.13.

Next year's average estimate for revenue is $3.50 billion. The average EPS estimate is $1.02.

Investor sentiment

Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on Forest Laboratories is outperform, with an average price target of $38.95.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
316%
 
S&P 500 Returns
112%

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 07/05/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.